Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke

Douglas J. Scothorn, Cynthia Price, Daniel Schwartz, Cindy Terrill, George R. Buchanan, Wanda Shurney, Ingrid Sarniak, Robert Fallon, Jen Yih Chu, Charles H. Pegelow, Winfred Wang, James F. Casella, Linda S. Resar, Brian Berman, Thomas Adamkiewicz, Lewis L. Hsu, Kwaku Ohene-Frempong, Kim Smith-Whitley, Donald Mahoney, J. Paul ScottGerald M. Woods, Masayo Watanabe, Michael R. DeBaun

Int Med - Chairman's Office
Pediatrics
Hematology & Oncology
Internal Medicine

Research output: Contribution to journal › Article › peer-review

202 Scopus citations

Sort by
Weight
Alphabetically

Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke

Fingerprint

Medicine & Life Sciences